Dr. Abou-Alfa and Prof. Lencioni have been involved in the development of Celsion’s lead product ThermoDox® for the treatment of HCC, or primary liver cancer. A review of the data supporting Celsion’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback